Pfizer is a healthcare company with sites in more than 150 countries around the world. It is divided into two main business segments. The first is pharmaceutical, which includes treatments for cardiovascular diseases, infectious diseases, central nervous system disorders, diabetes, arthritis, urogenital conditions and allergies, as well as the manufacture of empty soft-gelatin capsules.
It also manufactures products for livestock and companion animals. The second is consumer products, which includes self-medications for oral care, upper respiratory health, eye care, skin care and gastrointestinal health.
Company movements
Pfizer acquires Wyeth
In October 2009, Pfizer completed its acquisition of Wyeth for $68bn (€52bn). For more on this please see Pfizer completes $68bn acquisition of US pharma rival Wyeth on ICIS news.
On 20 July 2009, Wyeth approved the merger agreement with Pfizer.
In January 2009, Pfizer agreed to buy Wyeth for around $68bn (€52bn). Pfizer agreed pay $50.19 per share through a combination of cash, debt and stock. The company said it had borrowed $22.5bn from a consortium of banks to help fund the acquisition.
Please go to ICIS news for more on this story.
Pharmaceuticals
The pharmaceutical segment includes Pfizer's human pharmaceutical and animal health businesses.
Pfizer Animal Health
Leading the way to better animal health care, Pfizer Animal Health discovers, develops, manufactures and sells products that improve the safety, quality and productivity of the food supply and helps pets live longer, healthier lives, the company claims.
Consumer Products
The consumer products segment consists of Pfizer's consumer healthcare business, a supplier of over-the-counter (OTC) medicines.
Pfizer
Strategy & Financial Highlights
On 20 July 2009, a merger agreement between Pfizer and Wyeth was approved, under which Pfizer will acquire Wyeth in a cash-and-stock transaction. The combined company is believed will create one of the most “diversified companies in the global health care industry”, with product offerings in growing therapeutic areas, a strong product pipeline, and leading scientific and manufacturing capabilities. ICIS also provides you with key financial data listed in table form.
More about Pfizer Strategy & Financial Highlights
News:
Get news on Pfizer plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database